Literature DB >> 1386350

Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa.

J Gong1, B Rosner, D G Rees, E L Berson, C A Weigel-DiFranco, E J Schaefer.   

Abstract

In 188 patients from separate families with various forms of retinitis pigmentosa (RP) and 91 normal subjects, plasma fatty acids were measured as a percentage of total plasma fatty acids, and their concentrations were determined using capillary-column gas-liquid chromatography. After controlling for the effects of age and gender, those with RP had significantly lower (P less than 0.01) mean plasma percentages and concentrations of the omega-3 fatty acids: 18:3 omega 3 (alpha-linolenic acid), 22:3 omega 3 (13,16,19 docosatriaenoic acid), and 22:6 omega 3 (docosahexaenoic acid, DHA) compared with the group of normal subjects. The mean percentages were reduced 15%, 14%, and 10%, respectively, below the mean percentages in normal subjects. Analysis by genetic type revealed that the X-linked and isolate forms of RP had significantly lower (P less than 0.01) mean percentage values for DHA (18% and 17%, respectively). Dominant and recessive forms of RP had DHA levels close to normal. Mean absolute plasma DHA concentrations in X-linked RP were not significantly different from the concentrations in the control subjects, although these levels were significantly lower in patients with isolate RP. These data identify the possibility that some forms of RP may have alterations in plasma omega-3 fatty acid metabolism resulting in decreased plasma DHA content. These observations await additional confirmation using an analysis of the fatty acid content of specific erythrocyte phospholipid classes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386350

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

1.  Photoreceptor outer segment phagocytosis attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis.

Authors:  Pranab K Mukherjee; Victor L Marcheselli; Juan Carlos de Rivero Vaccari; William C Gordon; Fannie E Jackson; Nicolas G Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

2.  Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.

Authors:  Nicolas G Bazan; Miguel F Molina; William C Gordon
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

3.  Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution.

Authors:  Kie Kasuga; Rong Yang; Timothy F Porter; Nitin Agrawal; Nicos A Petasis; Daniel Irimia; Mehmet Toner; Charles N Serhan
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 4.  Resolution of acute inflammation in the lung.

Authors:  Bruce D Levy; Charles N Serhan
Journal:  Annu Rev Physiol       Date:  2013-12-02       Impact factor: 19.318

Review 5.  Resolvins: natural agonists for resolution of pulmonary inflammation.

Authors:  Mohib Uddin; Bruce D Levy
Journal:  Prog Lipid Res       Date:  2010-09-29       Impact factor: 16.195

6.  Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial.

Authors:  Dennis R Hoffman; Dianna K Hughbanks-Wheaton; N Shirlene Pearson; Gary E Fish; Rand Spencer; Alison Takacs; Martin Klein; Kirsten G Locke; David G Birch
Journal:  JAMA Ophthalmol       Date:  2014-07       Impact factor: 7.389

Review 7.  Lipid signaling in neural plasticity, brain repair, and neuroprotection.

Authors:  Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

8.  High levels of retinal docosahexaenoic acid do not protect photoreceptor degeneration in VPP transgenic mice.

Authors:  Feng Li; Lea D Marchette; Richard S Brush; Michael H Elliott; Kimberly R Davis; Ashley G Anderson; Robert E Anderson
Journal:  Mol Vis       Date:  2010-08-18       Impact factor: 2.367

Review 9.  Resolution of inflammation in asthma.

Authors:  Bruce D Levy; Isabelle Vachier; Charles N Serhan
Journal:  Clin Chest Med       Date:  2012-07-25       Impact factor: 2.878

10.  Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.

Authors:  K-in Cho; H Yi; A Yeh; N Tserentsoodol; L Cuadrado; K Searle; Y Hao; P A Ferreira
Journal:  Cell Death Differ       Date:  2008-10-24       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.